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Left Ventricular Hypertrophy and Morphology in Familial
Hypertrophic Cardiomyopathy Associated With Mutations of the
Beta-Myosin Heavy Chain Gene
SCOTT D. SOLOMON, MD,* SIMONETTA WOLFF, MD,* HUGH WATKINS, MRCP,*t
PAUL M . RIDKER, MD,* PATRICIA COME, MD, FACC,* WILLIAM J . McKENNA, MD, FACC,t
CHRISTINE E. SEIDMAN, MD,* RICHARD T. LEE, MD. FACC*
Batton, Massachusetts and London . England, United Kingdom
Objectives . The purpose of this study was to determine the
spectrum of left ventricular hypertrophy and ventricular mor-
phology in adults with hypertrophic cardlomyopathy due to
mutations of the beta•ntyosln heavy-chain gene .
Background. Although echocardiography Is an Important test
in diagnosing hypertrophy cardiontyopathy, the lack of an inde-
pendent diagnostic criterion has been an obstacle In determining
the fall ecitOCardiograpIic spectrum of this disease. Mutations in
the beta-myosin heavy chain gene occur In approximately 50% of
familial cases; In members of families with a known mutation, the
diagnosis can be made with certainty .
Methods. Echocardlogrants from 39 genetically affected and 30
genetically unaffected adult family members over age 16 years
from 10 families weft analyzed. Lent ventricular wall thickness
was measured at 10 separate locations, and the presence of systolic
anterior motion of the mitral valve, right ventricular hypertrophy
and left ventricular morphology was evaluated independently by
three separate observers without knowledge of the genetic diag-
nosis .
Recall. The mean max,rdVAl v0 thickness In the genetically
Since the initial clinical description of hypertrophic cardio-
myopathy, the criteria for diagnosis of the disease have
reflected the available diagnostic modalities (1) . At present,
two-dimensional echocardiography is believed to provide
the most information about morphologic and hemodynamic
features of the disease (2-6). A major obstacle in determin-
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affected group was 24 ± S mm (range t I to 40), compared with
11 ± 2 mm. (range 7 to 16) in the unaffected group (p < 0 .0001).
Systolic anterior motion of the mitral valve or chords tendineac
with or without leaflet-septal contact was present In 62% of the
affected group and in none of the unaffected group. The morpho-
logic finding of reversed septal curvature was present in 79% of
the affected group and in none of the unaffected group . Seventy
seven pacent of patients in the affected group bad a septallfree
wall ratio ; 1 .3 compared with 6% in the unaffected group, with
a septal/posterior wall ratio }13 associated with only a 55%
probability of being affected.
Conclusions. The two-dimensional echocardiographic spec-
trum of hypertrophic cardiomyopathy In a genetically defined
adult population is broad. Previous echocardiographic criteria
may be too strict to diagnose the disease in some patients who are
genetically affected and therefore at risk for adverse events related
to the disease . Ultimately, genetic testing may supersede echocar-
diography
in diagnosing hypertrophic cardiomyopathy .
('I Am Coil Cardiol 1993;22.498-505)
ing the full echocardiographic spectrum of abnormalities in
hypertrophic cardiomyopathy has been the lack of an inde-
pendent diagnostic criterion, and previous studies that have
examined echocardiographic manifestations of hypertrophic
cardiomyopathy have generally bastbd the diagnosis itself on
echocardiographic criteria, making an accurate assessment
of the full spectrum of echocardiographic features and their
frequencies impossible .
Recently, the genetic basis for hypertrophic cardiomyop-
athy in many families has been localized to the cardiac
beta-myosin heavy chain gene on chromosome 14 (7-10) .
Missense mutations in the beta-myosin heavy chain gene are
responsible for hypertrophic cardiomyopathy in approxi-
mately 50% of families studied (11,12) . Nine missense mu-
tations of the beta-myosin heavy-chain gene have been
identified, some of which are present in more than one family
(12-14). In families with a proved mutation of this gene,
members can be genotyped with certainty. This study exam-
ines the spectrum of ventricular hypertrophy and other
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morp~oloeic features in adults over age 16 years who are
genetically at risk for hypertrophic cardiomyopathy utilizing
genotype as the diagnostic criterion for determining affected
status.
Methods
Subjects . Seventy-four persons over age 16 years from 10
families who participated in the hypertrophic cardiomyopa-
thy genetics studies and in whom genetic analyses were
performed were screened for inclusion in the study . The
investigational protocol was approved by the Institutional
Review Board, and all subjects provided informed consent .
Three subjects were excluded because of poor quality
echocardiograms, as were two subjects who had undergone
previous myomectomy, leaving 69 for analysis . All subjects
included in the study were considered genetically at risk for
the disease ; that is, they ', d a known affected parent or
sibling. Thirty-nine subjects were genetically affected, and
30 were genetically unaffected, as determined by genetic
studies described later. One of the unaffected and none of
the affected cohort had a history of hypertension . None of
the subjects included in the study were known to have aortic
valve disease.
Echocardiographic methods. Echocardiograms were per-
formed at three separate institutions utilizing standard
echocardiographic systems . All analyzed studies contained
standard two-dimensional echocardiographic views :
parasternal long axis, parasternal short-axis at the mitral
valve and papillary muscle levels, apical four- and two-
chamber and subcostal .
Tw6-dimensional echocardiographic measurements . All
echocardit, raphic measurements were performed in a core
laboratory, with the examiner performing the analysis with-
out knowledge of the genetic diagnoses. End-diastolic left
ventricular wall thickness measurements were obtained at 10
separate locations from the parasternal short- and long-axis
views ; measurements from three separate beats for each
location were averaged . Ventricular wall thickness for the
anterior, lateral free wall, posterior free wall and inferior
walls ;n the parasternal short-axis view were obtained at
both the mitral valve and papillary muscle levels . Septal and
posterior wall thicJ -pss and left ventricular end-diastolic
and end-systolic diameter measurements were also obtained
from the parasternal long-axis view . To avoid off axis mea-
surements, measurements in the short axis were made only
when the cavity appeared circular (2) .
Qualitative features . Qualitative two-dimensional
echocardiographic features were evaluated independently by
three echocardiographers who were unaware of the genetic
diagnoses . These features included the presence or absence
of systolic anterior motion of the mitral valve, the presence
or absence of right ventricular hypertrophy, the location of
predominant hypertrophy and ventricular morphology . Sys-
tolic anterior motion of the mitral valve was classified by
each observer as none, chordal only or involving the anterior
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Figure 1. Ventricular morphologies classified in this study. LA =
left atrium ; LV = left ventricle ; RA = right atrium ; RL = right
ventricle .
mitral leaflet . It was considered present if anterior move-
ment of the mitral valve leaflets during systole could be
visualized by two-dimensional echocardiography and did not
require the presence of full leaflet-septal contact . Right
ventricular hypertrophy was considered present if right
ventricular free wall thickness in the subcostal view ex-
ceeded 7 mm (15) . The pattern of left ventricular hypertro-
phy was classified according to the method of Maron et al .
(16) as 1) no hypertrophy, 2) predominantly anterior septal
hypertrophy, 3) diffuse concentric hypertrophy, 4) hypertro-
phy of the anterior and posterior septum with sparing of the
free wall, or 5) hypertrophy of the anterolateral free wall,
apex or posterior septum (16) . Ventricular morphology was
classified as 1) normal, 2) hypertrophied with reversed septal
curvature, 3) hypertrophied with proximal septal bulge, or
4) hypertrophied with normal shape (Fig . 1) (17) .
I chocardiographic data analysis . The maximal wall thick-
ness from any location was determined. In addition, a
septai/posterior wall ratio was obtained from the ratio of
septallposterior wall thickness in the parasternal long-axis
view, the short-axis view at the mitral valve level or the
short-axis view at the papillary muscle level . We devised an
index of ventricular asymmetry based on the variance of the
mean wall thickness measurements in the short-axis views,
with a perfectly symmetric ventricle having a wall thickness
variance of zero . Wall thickness variance was calculated at
both the mitral valve and papillary muscle levels by the
following formula-.
E(x x)2
Wall thickness variance = - d
where x = is the wall thickness for each of four wall
thickness measurements in the short-axis view at the appro-
priate level .
Genetic analysis.
Genotypic assessment was performed
by polymerase chain reaction, as previously described (12)
.
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Table 1
. Echocardiographic Characteristics of 19 Genetically Affected Patients
*Mutation associated with change in charge. Pt
=
patient ; F = female ; M = male .
Individual subjects were determined to be genetically af-
fected or unaffected on the basis of the presence or absence
of a missense mutation of the beta-myosin heavy chant gene .
The distribution of missense mutations in the families in-
cluded in this study is shown in Table 1 .
Shti Ical analysis. Differences in mean values between
affected and unaffected cohorts were compared with the
Student t test for continuous measured variables when tests
for normality were satisfied; the Wilcoxon rank-sum test was
used for continuous variables for data that were not normally
distributed or could not be easily transformed, The chi-
square test was applied to categoric variables . Univariate
logistic regression analyses were used to derive the proba
bility of affected status on the basis of maximal wall thick-
JAM Vol. ZZ, NO. L
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ness or septal/posterior wall ratio. In addition, multivariate
logistic regression analyses were used to determine whether
maximal wall thickness, septallposterior wall ratio, age, wall
thickness variance or right ventricular hypertrophy were
independently predictive of affected status .
Interobserver agreement. There was complete agrreemenl
among all three observers for qualitative features in 92% of
patients for systolic anterior motion, 130% of patients for
right ventricular hypertrophy, 90% of patients for ventriculat
morphology and 88% of patients for location of hypertrophy .
There was only one instance of complete disagreement
among three observers in the location of hypertrophy ; this
occurred in an affected subject with a maximal wall thick.
ness of 35 mm and extensive hypertrophy .
P1
No . Age (yi /Gender
Maximal wall
Thickness
(mm)
Septal/Posterior
Wall Ratio
Systolic Anterior
Motion
Right
Ventricular
Hypertrophy
Reversed Septa]
Curvature Mutation
1 IS/M
18
1.09 Yes
No
No
Arg 403-+ Gin*
2
231M 30
1 .31 Yes
Yes Yes Arg 403 -~ Gin-
3
21/M
23 2 .25
Yes No Yes Alg 403
-
Gin*
4
451M 25
3 .03 Yes Na Yes Arg 403-* GIn*
5 441F 27
2 .27 No No
Yes
Arg 403--' Gin-
6 23/F 16
1 .51 No No
No Arg 403 -* GIn*
7 22/M
25 2 .84
Yes No Yes Arg 403-* Gin*
8
23/F 22
1
.26
Yes Yes Yes Arg 403 -* Gin*
9 22/F 38
3 .57 Yes Yes Yes Arg 403
.
Gin*
10
471F 12
0.86 Yes Yes Yes Arg 403 -~ Gin*
11 29/F 26
1.32 Yes No
yes Ars 403 Gin*
12 41/F 26
1 .18 No
No No Ars 403 -y Gin*
13 171M 35
1 .50 Yes Yes Yes Arg 403 -. Gin*
14 421F 26
2 .26 No Yes Yes Arg 403 -' Gin*
IS 22/F IS
2,30 Yes No Yes kg 403 -' Gln*
16 241F 14
1 .57 Yes
Yes
Yes Arg 403 Gin*
17 23/M
39 1 .40 Yes
No
Yes
Arg 403 Gin*
18 441M
16 1 .75 No No Yes Arg 403 Gin*
19 59/M 35
2
.33
No No Yes Gin 949
-.
Lys'
20 37M 14
1 .16 No No No Gin 949-• Lys*
21
241F 26 2 .07 Yes No Yes Arg 453-'. Cys*
22 40/F 20 1 .54 No
No
Yes Arg 453 Cys*
23 45/F 29
1 .44
No
No Yes Arg 453 i Cys*
24 231M
40 2.25 Yes Yes Yes Arg 453 -~ Cys*
25 23/M 20 1 .55 No No No Arg 453 -* Cys*
26 25/M 31 2.09 Yes No Yes Gly 584 -~ Arg*
27 61/M 23
1
.87 No No Yes Gly 584-+ Arg*
28
30VM 18 1.50
Yes No Yes Gly 584-+ Arg*
29 45/F 19 1 .36 Yes No Yes Vat 606 -> Met
30 27/M 23 2 .00 Yes No Yes Val 606 -. Met
31 27/M 17 1 .83 Yes No Yes Val 606 -> Met
32 19/F 14 1
.06 No
No
No Val 606 -. Met
33 50VF 36 2 .50
No No No Val 606-+ Met
34 42>F' I1 1 .10 No No No Val 606-+ Met
3S 25/F 32 1 .96 Yes Yes Yes
Val 606-* Met
36 201M
20 1 .50 Yes No Yes Val 606-' Met
37 58/M
24
1 .00
No No Yes Val 606-' Met
38 46/F 18 1 .10
No Yes Yes Glu 924-• Lys*
39 241F 21 1 .72
No No Yes Glu 924 -' Lys*
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Table 2. Wall Thickness Measurements at Various Locations in
69 Subjects
Values are mean value (mm) and SD ; range .
Results
Echocardiographic characteristics of genetically affected
subjects in this study are shown in Table 1 . The ages of those
studied ranged from 16 to 61 years (mean 33 ± 13) in the
genetically affected group, compared with 19 to 70 years
(mean 41 ± 13) in the unaffected group (p = 0 .01). Twenty of
the 39 affected subjects were women, as were 14 of the 30
unaffected subjects . A total of six mutations of the beta-
myosin heavy-chain gene were represented in the families
studied ; all of these mutations cause a change in amino acid
charge, with the exception of the Val 606
-
Met mutation,
which does not result in a change in amino acid charge .
Wall thickness measurements . The mean wall thickness
measurements at various locations and from various views
are shown in Table 2 . The mean maximal wall thickness at
any location was II t 2 mm in the unaffected cohort and
24 ± 8 mm in the affected cohort (Fig . 2) (p < 0 .0001). The
Figure 2. Maximal wall thickness in unaffected and affected pa-
tients . Small circles represent individual patients . Mean value ± SD
is also shown for each group. HCM = hypertrophic cardiomyopa-
thy .
20-
Unaffected
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Figure 3. Septalfposterior wall ratio in unaffected and affected
patients . Symbols and abbreviations as in Figure 2 .
maximal wall thickness in the unaffected cohort was 17 mm,
in a subject with a known history of hypertension . The
maximal wall thickness in unaffected subjects without a
history of hypertension was 13 mm . In the affected cohort, I
patient had a maximal wall thickness < 12 mm, 4 patients had
a maximal wall thickness between 12 and 15 mm, 9 had a
maximal wall thickness between 15 and 20 mm and 25 had a
maximal wall thickness >20 mm. The minimal wall thickness
of any patient in the affected cohort was 11 mm . This patient
was a 42-year old woman with a normal electrocardiogram
who also had no evidence of systolic anterior mitral valve
motion, right ventricular hypertrophy or abnormal ventric-
ular morphology .
The mean septal/posterior wall ratio was 1 .10 ± 0.2 in the
unaffected group (range 0 .67 to 1 .77) compared with 1 .75 ±
0.6 (range 0 .86 to 3.6) in the affected cohort, as shown in
Figure 3 . Seventy-seven percent of patients in the affected
group had a septal/posterior wall ratio z 1 .3 compared with
6% in the unaffected group . There was no significant asso-
ciation between age and extent of hypertrophy in either the
affected or the unaffected cohort . The mean wall thickness
variance at the mitral valve level for the unaffected cohort
was 0.03 t 0 .03 (range 0.003 to 0.12) compared with 0.49 ±
0.48 (range 0.001 to 1 .87) for the affected cohort (p <
0.0001)
. At the papillary muscle level, mean wall thickness
variance was 0.02 t 0.02 (range 0.0003 to 0
.1) for the
unaffected cohort compared with 0 .44 t 0.47 (range 0 .001 to
1 .87) for the affected cohort (p < 0 .0001). Of nine affected
patients with a septallposterior wall ratio <1 .3, four had a
wall thickness variance >2 SD from the mean of the unaf-
fected group, suggesting that this measure provides addi-
tional information beyond that of septal/posterior wall ratio.
The most asymmetric ventricle in the unaffected cohort had
a wall thickness variance of 0 .12 (mean 0
.03), whereas the
mean wall thickness variance in the affected cohort was 0,49,
indicating that ventricular asymmetry was much more ex-
tensive in the affected group .
Unaffected
Group
(n = 30)
Affected
Group
(n = 39) p Value
Mil-.al valve level
Anteroseptal I1
t
1 .6 ; 9-15 20 ± 7 ; 9-31 < 0.0001
Lateral 9 ± 1 .7 ; 7-15 12 ± 4 .5 ; 6-30 < 0.01
Posterior 8 ± 1 .3,5-10 11 14
.4 ; 6-30 < 0.01
Inferior 8 ± 1 .7,6-14 11 ± 4.9; 6-30
< 0.05
Papillary muscle level
Anteroseptal 10 ± 2 .0 ; 7--17 22 ± 8.1 ; 9-40 < 0.0001
Lateral 9 ± 2 .0,6-17 12 ± 4.4; 7-30 < 0.01
Posterior 9 ± 1 .6,6-12 11
± 4.4 ; 6-30
< 0.01
Inferior
9 ± 1 .8 ; 6-15
12
± 5.2 ; 6.5-30 < 0.01
Parasternallong axis
Anteroseptal 10 ± 1 .8 ; 5-14 21 ± 7 .7 ; 10-38 < 0.0001
Posterior 8 ± 1 .8 ; S-13 10 ± 4.1 6-30 < 0.05
Maximal wall thickness 11 ± 2.0 ; 7-16 24 ± 8 ; 11-40 < 0 .0001
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Table 3
. Qualitative rchecardiographic Features in 69 Subjects
Qualkative echocardiographie features. Table 3 demon-
strates the qualitative echocardiographic features observed
in unaffected and affected subjects . In the affected cohort,
76% had left ventricular hypertrophy primarily of the ante-
rior septum, two patients (5%) had hypertrophy that was
relatively equal in the anterior and posterior walls and one
patient had hypertrophy primarily involving the right ventri-
cle . Twenty-six percent of patients in the affected cohort had
right ventricular hypero ;n ophy, compared with 7% of subjects
in the unaffected cohort (p < 0 .04). Seventy-nine percent of
patients in the affected cohort had the morphology of re-
versed septal curvature in the four-chamber apical view
compared with none in the unaffected cohort (p < 0.0001) .
Of affected patients with reversed septa[ ctrvature, five had
a septal/posterior wall ratio < 1 .3, suggesting that this finding
was not simply an artifact of ventricular asymmetry . Seven •
teen percent of patients in the affected cohort had qualitative
evidence of left ventricular hypertrophy with normal ven-
tricular morphology. No patients in either the erected or the
unaffected cohort had ventricular hypertrophy that was
confined to the proximal septum,
Systolic anterior motion of the mitral valve leaflets was
present in 44% of affected patients, and I of affected
patients had chordal systolic anterior motion only (p <
0,0001). None of the unaffected subjects had either chordal
systolic anterior motion or systolic anterior motion involving
the mitral valve leaflet . Two affected subjects with systolic
anterior motion of the mitral valve had a maximal left
ventricular wall thickness <1S mm, and three subjects with
systolic anterior motion had a septallposterior wall ratio
<1 .3 .
In a univariate logistic regression analysis, maximal wall
thickness, septallposterior wall ratio and wall thickness
variance were found to be significant predictors of affected
status
. Figures 4 and 5 demonstrate the probability of
affected status at any given wall thickness or septallfree wall
ratio, derived from a logistic regression using either maximal
wail thickness or septallposterior wall ratio as a continuous
dependent variable
. A patient genetically at risk for the
disease with a wall thickness 216 mm or a septal/posterior
wall ratio a 1 .5 had a -75% probability of being affected ; a
maximal wall thickness 2:18 mm or a septal/posterior wall
ratio t1,87 was associated with a >95% probability of being
affected . 0f note, a septallposterior wall ratio ->1 .3, which
has previously been proposed as a diagnostic criterion (18),
conferred a probability of 55% of beii
E affected in this
patient group .
To determine which variables present among affected and
unaffected subjects were most predictive of genotype posi-
tivity, a backward stepwise multiple logistic regression anal-
ysis was performed, incorporating affected status as the
dependent variable and maximal wall thickness, septal/
posterior wall ratio, age, wall thickness variance and right
ventricular hypertrophy as the independent variables . In this
model, maximal wall thickness was the only variable that
was independently predictive of genotype positivity (p <
0.02) . Systolic anterior motion and abnormal ventricular
morphology were seen only in patients with affected status
and were therefore not included in this model .
Of the genetically affected subjects in this study, three
had a maximal left ventricular wall thickness <15 mm,
Figure 4. Probability of affected status at any given maximal wall
thickness derived from a univariate logistic regression model
.
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Figure 5. Probability of affected status at any given septallposterior
wall ratio derived from a univariate logistic regression model .
septal/posterior wall ratio a 1 .3 and no evidence of systolic
anterior motion of the mitral valve, right ventricular hyper-
trophy or abnormal ventricular morphology . Two of these
subjects had the Val 606 -* Met mutation, not associated
with a change in amino acid charge, and the remaining
subject had the Glu 949--b Lys mutation, which is associated
with a change in amino acid charge . One affected subject
with a maximal wall thickness of 12 mm had a septall
posterior wall ratio of 0 .8, systolic anterior motion of the
mitral valve, right ventricular hypertrophy and reversed
septal curvature . Three affected subjects with different mu-
tations had significant left ventricular hypertrophy (> 15 mm)
but no evidence of systolic anterior motion of the mitral
valve, right ventricular hypertrophy or abnormal ventricular
morphology .
Discussion
By utilizing genotype as an independent diagnostic crite-
rion for hypertrophic cardiomyopathy, this study describes
the spectrum of two-dimensional echocardiographic abnor-
malities in the disease more completely than has been
possible in studies that have relied on echocardiographic
diagnosis to ideuti€y affected patients . The results of this
study indicate that the range of abnormalities in familial
hypertrophic cardiomyopathy is broad and that when ap-
plied to a population at risk for the disease, previously
described diagnostic criteria may lack both sensitivity and
specificity . This study confirms previous observations that
there is significant heterogeneity of echocardiographic find-
ings in hypertrophic cardiomyopathy and extends these
observations to patients with missense mutations of the
beta-myosin heavy chain gene .
Despite the myriad of abnormalities described in hyper-
trophic cardiomyopathy, many investigators have suggested
that unexplained ventricular hypertrophy represents the
primary morphologic abnormality of the disease (19) . Be-
SOLOMON ET AL
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cause familial hypertrophic cardiomyopathy is inherited as
an autosomal dominant trait with a penetrance that is >95%
(7,11), persons who carry the gene would be expected to
demonstrate some phenotypic evidence of the disease
. This
study confirms previous observations that although the
majority of genetically affected persons demonstrate
echocardiographic evidence of the disease, it is possible for
affected adults who share a mutation with persons who are
severely affected to have no echocardiographic evidence of
disease (20) . Whether these persons arc at risk for arrhyth-
mia or sudden death is currently unknown, although familial
cases of sudden death have been reported (21) that have the
characteristic histologic features of hypertrophic cardiomy-
opathy but no echocardiographic finding ;: .
Asymmetric septal hypertrophy. Asymmetric septal hy-
pertrophy has been considered a hallmark of this disease,
with a septal/posterior wall ratio ;~1 .3:1 regarded as diag-
nostic (22) . In our study group, a septal/posterior wall ratio
1 .3 had a sensitivity of 0 .77, a specificity of 0 .93, a positive
predictive value of 0.94 and a negative predictive value of
0.76 for the diagnosis of affected status . Even in this highly
enriched group, these indicators are not adequate for defin-
itive diagnosis of the disorder . Because this is a group in
which the a priori risk of having the disease is 50%, the
echocardiographic diagnostic criteria used to assess whether
an individual patient is affected must have a predictive value
well above 50% . In our subjects, systolic anterior motion
and reverse septa) curvature had the best predictive values
(100%), and a maximal wall thickness of 15 mm or a
septal/posterior wall ratio of 1 .5 was associated with a 75%
probability of being affected . In an unselected group, these
criteria are likely to be far less specific and less predictive .
Like septal/posterior wall ratio, the wall thickness vari-
ance quantifies the extent of ventricular asymmetry . The
distribution of wall thickness variance in the normal cohort
approached a perfectly symmetric score of zero, whereas the
affected cohort had significantly greater asymmetry . Al-
though the abnormal sepvil/posterior wall ratio in the af-
fected cohort was probably a major contributor to asymme-
try, wall thickness variance was independently predictive of
genotype when controlling for septaUposterior wall ratio.
Systolic anterior motion. The presence of systolic ante-
rior motion of the mitral valve usually correlates with the
severity of outflow tract obstruction and is associated with
septal hypertrophy (23) . Previous studies have found that the
diagnostic specificity of systolic anterior motion of the mitral
valve for hypertrophic cardiomyopathy is 97% (7A) . In the
present study, systolic anterior motion was characterized as
either chordal or involving the mitral leaflets and did not
further distinguish systolic anterior motion in which the
anterior mitral valve leaflet apposed the septum . The percent
of affected patients with leaflet systolic anterior motion in
our study is similar to that previously described in patients
with hypertrophic cardiomyopathy . Although Shapiro and
McKenna (2) noted systolic anterior motion of the mitral
valve in 47% of patients with hypertrophic
cardiomyopathy,
JACC Vol. 22, No . 2
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other investigators (17,25) noted a greater prevalence of this
finding, a difference that may reflect selection bias
. In our
study group, chordal
systolic anterior motion was seen only
in affected subjects, suggesting that inclusion of chordal
systolic anterior motion in the definition of systolic anterior
motion may increase its sensitivity as a diagnostic criterion .
Ven&k,vbr morphology
. The left ventricular cavity in
many patients with hypertrophic cardiomyopathy has been
characterized as sigmoid, or "quarter-moon" in shape, with
the septum bowing into the ventricular cavity (17) . Lever et
al. (17) used this criterion to distinguish hypertrophic car-
diomyopathy in the elderly, a disease probably related to
hypertension, from hypertrophic cardiomyopathy in the
young. In their study group, only young patients with
hypertrophic cardiomyopathy demonstrated reversed septal
curvature, and a proximal septa) bulge was seen only in
elderly patients, Whereas seven of eight affected subjects
with normal ventricular morphology in our cohort had
hypertrophy, none of the affected in our cohort had hyper-
trophy isolated to the proximal septum. The sigmoid-shaped
septum visualized in affected subjects in our study may
reflect a pattern of hypertrophy in which the predominant
hypertrophy occurs in the mid rather than the distal septum ;
nevertheless, this pattern is visually striking and may be
useful in distinguishing hypertrophic cardiomyopathy from
hypertrophy of other causes .
Study limitations. Because of the absence of Doppler
evaluation in many patients, Doppler variables were not
included in the analysis . Hemodynamic assessment of out-
flow gradients based on Doppler studies have added signifi-
cantly to the understanding of hypertrophic cardiomyopa-
thy. Nevertheless, outflow tract gradients can vary
tremendously in individual patients over time and may not
be present in a substantial number of patients corsidered to
have hypertrophic cardiomyopathy. In addition, the relation
between systolic anterior motion of the mitral valve and
outflow tract obstruction in this patient group could not be
addressed,
The data presented in this study do not address the
sensitivity or specificity of these various diagnostic criteria
in the population at large but reflect the findings of a specific,
highly enriched population of persons who are genetically at
risk for the disease . Clinicians are often faced with the
practical problem of diagnosing hypertrophic cardiomyopa-
thy in a family member of a known affected individual. The
unaffected family members therefore serve as an appropriate
and realistic control group even though they were not
matched with the affected cohort
. Our results are thus
applicable to the adult population that is genetically at risk
for the disease, although there is no reason to assume that
the unaffected subjects analyzed in this study differ substan-
tially from the normal population. Because echocardiograms
were not available for a sufficient number of children in these
families, this analysis was confined to family members over
age 16 years. The results of this study should not be
extrapolated to genetically affected or possibly affected
children because they will be less likely to manifest clinical
or echocardiographic findings of hypertrophic cardiomyop-
athy .
For the purposes of this analysis, members of 10 families
were determined to be genotype positive if they demon-
strated any of seven missense mutations of the beta-myosin
heavy chain gene. Studies of other genetic diseases due to
missense mutations, including cystic fibrosis, have demon-
strated similar phenotypic characteristics from a variety of
mutations of a single gene (26), although major phenotypic
differences have been observed in patients with distinct
mutations of the same gene. In this study, there were no
overt differences in the echocardiographic characteristics
seen in affected persons with distinct missense mutations .
Although this study lacked adequate power to detect signif-
icant differences in echocardiographic characteristics asso-
ciated with distinct missense mutations of the beta-myosin
heavy chain gene (Table I), the possibility that distinct
missense mutations in the beta-myosin heavy chain gene are
associated with differences in phenotypic expression re-
mains .
Conclusions. In this study, there was no echocardio-
graphic sine qua non for the diagnosis of hypertrophic
cardiomyopathy, and no single echocardiographic finding
was pathognomonic for the disease. The broad range of
echocardiographic findings in the affected subjects included
in this study should, for the clinician, raise the possibility
that a patient may be genetically affected even without
"classic" echocardiographic manifestations. Indeed, pa-
tients without echocardiographic evidence of the disease
who are genetically affected may be at risk for arrhythmia or
sudden death. The clinical characteristics of genetically
affected persons who lack major phenotypic characteristics
of the disease remain uncertain . Mutations in the: beta-
myosin heavy chain gene account for approximately half of
the familial cases oY hypertrophic cardiomyopathy
(12,27,28), and our laboratory has recently demonstrated
mutations in the beta myosin heavy chain gene in nonfamil-
ial cases (14) . Although echocardiography will continue to
play an impsc cant role in the diagnosis and management of
patients with hypertrophic cardiomyopathy, genetic testing,
when widely available, may supersede echocardiography as
the test of choice for diagnosis in members of affected
families .
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